Childrens Simethicone Drops Liquid
NDC Package 0121-1095-03
Package Information
Childrens Simethicone Drops liquids is a medication used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy). This formulation utilizes a liquid delivery system. Marketed by Pai Holdings, Llc Dba Pai Pharma, this product is identified by NDC 0121-1095 and is authorized under FDA application M002.
Identification & Billing
- RxCUI: 198857 - simethicone 20 MG in 0.3 mL Oral Suspension
- RxCUI: 198857 - simethicone 66.7 MG/ML Oral Suspension
- RxCUI: 198857 - simethicone 20 MG per 0.3 ML Oral Suspension
- RxCUI: 198857 - simethicone 40 MG per 0.6 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0121 - Pai Holdings, Llc Dba Pai Pharma
- 0121-1095 - Childrens Simethicone Drops
- 0121-1095-03 - 25 SYRINGE, PLASTIC in 1 CARTON / .6 mL in 1 SYRINGE, PLASTIC (0121-1095-01)
- 0121-1095 - Childrens Simethicone Drops
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0121-1095-03 identifies a specific commercial package of 25 syringe, plastic in 1 carton / .6 ml in 1 syringe, plastic (0121-1095-01) of Childrens Simethicone Drops, a human over the counter drug labeled by Pai Holdings, Llc Dba Pai Pharma. This liquid is formulated for oral use and contains dimethicone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pai Holdings, Llc Dba Pai Pharma on June 08, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy). Emollients are substances that soften and moisturize the skin and decrease itching and flaking. Some products (e.g., zinc oxide, white petrolatum) are used mostly to protect the skin against irritation (e.g., from wetness). Dry skin is caused by a loss of water in the upper layer of the skin. Emollients/moisturizers work by forming an oily layer on the top of the skin that traps water in the skin. Petrolatum, lanolin, mineral oil and dimethicone are common emollients. Humectants, including glycerin, lecithin, and propylene glycol, draw water into the outer layer of skin. Many products also have ingredients that soften the horny substance (keratin) that holds the top layer of skin cells together (including urea, alpha hydroxy acids such as lactic/citric/glycolic acid, and allantoin). This helps the dead skin cells fall off, helps the skin keep in more water, and leaves the skin feeling smoother and softer.
How is this Pai Holdings, Llc Dba Pai Pharma product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00121109503. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.